Selected research
Industry Research
Plasmid DNA (pDNA) Industry Research Report 2026
Market perspective
The global Plasmid DNA (pDNA) market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Plasmid DNA (pDNA) market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Plasmid DNA (pDNA) market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Plasmid DNA (pDNA) market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Plasmid DNA (pDNA) include GenScript Biotech, Xpress Biologics, WuXi Advanced Therapies, Waisman Biomanufacturing, Takara Bio, Synbio Technologies, Recipharm, Patheon and GenScript ProBio, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Plasmid DNA (pDNA) market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Plasmid DNA (pDNA).
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Plasmid DNA (pDNA) Market by Company
GenScript Biotech
Xpress Biologics
WuXi Advanced Therapies
Waisman Biomanufacturing
Takara Bio
Synbio Technologies
Recipharm
Patheon
GenScript ProBio
Eurogentec
Esco Aster
Creative Biolabs
Charles River Laboratories
Catalent Biologics
Biovian
Andelyn Biosciences
Aldevron
Akron Biotech
AGC Biologics
Plasmid DNA (pDNA) Segment by Type
Research Grade Plasmid DNA
Commercial Grade Plasmid DNA
Plasmid DNA (pDNA) Segment by Application
Cancers
Viral Infections
Inherited Disorders
Other
Plasmid DNA (pDNA) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plasmid DNA (pDNA) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Plasmid DNA (pDNA) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plasmid DNA (pDNA).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Plasmid DNA (pDNA) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Research Grade Plasmid DNA
- Commercial Grade Plasmid DNA
Applications
- Cancers
- Viral Infections
- Inherited Disorders
- Other
Companies covered
- GenScript Biotech
- Xpress Biologics
- WuXi Advanced Therapies
- Waisman Biomanufacturing
- Takara Bio
- Synbio Technologies
- Recipharm
- Patheon
- GenScript ProBio
- Eurogentec
- Esco Aster
- Creative Biolabs
- Charles River Laboratories
- Catalent Biologics
- Biovian
- Andelyn Biosciences
- Aldevron
- Akron Biotech
- AGC Biologics
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Plasmid DNA (pDNA) by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Research Grade Plasmid DNA
- 2.2.3 Commercial Grade Plasmid DNA
- 2.3 Plasmid DNA (pDNA) by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Cancers
- 2.3.3 Viral Infections
- 2.3.4 Inherited Disorders
- 2.3.5 Other
- 2.4 Assumptions and Limitations
3 Plasmid DNA (pDNA) Breakdown Data by Type
- 3.1 Global Plasmid DNA (pDNA) Historic Market Size by Type (2021-2026)
- 3.2 Global Plasmid DNA (pDNA) Forecasted Market Size by Type (2027-2032)
4 Plasmid DNA (pDNA) Breakdown Data by Application
- 4.1 Global Plasmid DNA (pDNA) Historic Market Size by Application (2021-2026)
- 4.2 Global Plasmid DNA (pDNA) Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Plasmid DNA (pDNA) Market Perspective (2021-2032)
- 5.2 Global Plasmid DNA (pDNA) Growth Trends by Region
- 5.2.1 Global Plasmid DNA (pDNA) Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Plasmid DNA (pDNA) Historic Market Size by Region (2021-2026)
- 5.2.3 Plasmid DNA (pDNA) Forecasted Market Size by Region (2027-2032)
- 5.3 Plasmid DNA (pDNA) Market Dynamics
- 5.3.1 Plasmid DNA (pDNA) Industry Trends
- 5.3.2 Plasmid DNA (pDNA) Market Drivers
- 5.3.3 Plasmid DNA (pDNA) Market Challenges
- 5.3.4 Plasmid DNA (pDNA) Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Plasmid DNA (pDNA) Players by Revenue
- 6.1.1 Global Top Plasmid DNA (pDNA) Players by Revenue (2021-2026)
- 6.1.2 Global Plasmid DNA (pDNA) Revenue Market Share by Players (2021-2026)
- 6.2 Global Plasmid DNA (pDNA) Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Plasmid DNA (pDNA) Head Office and Area Served
- 6.4 Global Plasmid DNA (pDNA) Players, Product Type & Application
- 6.5 Global Plasmid DNA (pDNA) Manufacturers Established Date
- 6.6 Global Plasmid DNA (pDNA) Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Plasmid DNA (pDNA) Market Size (2021-2032)
- 7.2 North America Plasmid DNA (pDNA) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Plasmid DNA (pDNA) Market Size by Country (2021-2026)
- 7.4 North America Plasmid DNA (pDNA) Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Plasmid DNA (pDNA) Market Size (2021-2032)
- 8.2 Europe Plasmid DNA (pDNA) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Plasmid DNA (pDNA) Market Size by Country (2021-2026)
- 8.4 Europe Plasmid DNA (pDNA) Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Plasmid DNA (pDNA) Market Size (2021-2032)
- 9.2 Asia-Pacific Plasmid DNA (pDNA) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Plasmid DNA (pDNA) Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Plasmid DNA (pDNA) Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Plasmid DNA (pDNA) Market Size (2021-2032)
- 10.2 South America Plasmid DNA (pDNA) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Plasmid DNA (pDNA) Market Size by Country (2021-2026)
- 10.4 South America Plasmid DNA (pDNA) Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Plasmid DNA (pDNA) Market Size (2021-2032)
- 11.2 Middle East & Africa Plasmid DNA (pDNA) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Plasmid DNA (pDNA) Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Plasmid DNA (pDNA) Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 GenScript Biotech
- 12.1.1 GenScript Biotech Company Information
- 12.1.2 GenScript Biotech Business Overview
- 12.1.3 GenScript Biotech Revenue in Plasmid DNA (pDNA) Business (2021-2026)
- 12.1.4 GenScript Biotech Plasmid DNA (pDNA) Product Portfolio
- 12.1.5 GenScript Biotech Recent Developments
- 12.2 Xpress Biologics
- 12.2.1 Xpress Biologics Company Information
- 12.2.2 Xpress Biologics Business Overview
- 12.2.3 Xpress Biologics Revenue in Plasmid DNA (pDNA) Business (2021-2026)
- 12.2.4 Xpress Biologics Plasmid DNA (pDNA) Product Portfolio
- 12.2.5 Xpress Biologics Recent Developments
- 12.3 WuXi Advanced Therapies
- 12.3.1 WuXi Advanced Therapies Company Information
- 12.3.2 WuXi Advanced Therapies Business Overview
- 12.3.3 WuXi Advanced Therapies Revenue in Plasmid DNA (pDNA) Business (2021-2026)
- 12.3.4 WuXi Advanced Therapies Plasmid DNA (pDNA) Product Portfolio
- 12.3.5 WuXi Advanced Therapies Recent Developments
- 12.4 Waisman Biomanufacturing
- 12.4.1 Waisman Biomanufacturing Company Information
- 12.4.2 Waisman Biomanufacturing Business Overview
- 12.4.3 Waisman Biomanufacturing Revenue in Plasmid DNA (pDNA) Business (2021-2026)
- 12.4.4 Waisman Biomanufacturing Plasmid DNA (pDNA) Product Portfolio
- 12.4.5 Waisman Biomanufacturing Recent Developments
- 12.5 Takara Bio
- 12.5.1 Takara Bio Company Information
- 12.5.2 Takara Bio Business Overview
- 12.5.3 Takara Bio Revenue in Plasmid DNA (pDNA) Business (2021-2026)
- 12.5.4 Takara Bio Plasmid DNA (pDNA) Product Portfolio
- 12.5.5 Takara Bio Recent Developments
- 12.6 Synbio Technologies
- 12.6.1 Synbio Technologies Company Information
- 12.6.2 Synbio Technologies Business Overview
- 12.6.3 Synbio Technologies Revenue in Plasmid DNA (pDNA) Business (2021-2026)
- 12.6.4 Synbio Technologies Plasmid DNA (pDNA) Product Portfolio
- 12.6.5 Synbio Technologies Recent Developments
- 12.7 Recipharm
- 12.7.1 Recipharm Company Information
- 12.7.2 Recipharm Business Overview
- 12.7.3 Recipharm Revenue in Plasmid DNA (pDNA) Business (2021-2026)
- 12.7.4 Recipharm Plasmid DNA (pDNA) Product Portfolio
- 12.7.5 Recipharm Recent Developments
- 12.8 Patheon
- 12.8.1 Patheon Company Information
- 12.8.2 Patheon Business Overview
- 12.8.3 Patheon Revenue in Plasmid DNA (pDNA) Business (2021-2026)
- 12.8.4 Patheon Plasmid DNA (pDNA) Product Portfolio
- 12.8.5 Patheon Recent Developments
- 12.9 GenScript ProBio
- 12.9.1 GenScript ProBio Company Information
- 12.9.2 GenScript ProBio Business Overview
- 12.9.3 GenScript ProBio Revenue in Plasmid DNA (pDNA) Business (2021-2026)
- 12.9.4 GenScript ProBio Plasmid DNA (pDNA) Product Portfolio
- 12.9.5 GenScript ProBio Recent Developments
- 12.10 Eurogentec
- 12.10.1 Eurogentec Company Information
- 12.10.2 Eurogentec Business Overview
- 12.10.3 Eurogentec Revenue in Plasmid DNA (pDNA) Business (2021-2026)
- 12.10.4 Eurogentec Plasmid DNA (pDNA) Product Portfolio
- 12.10.5 Eurogentec Recent Developments
- 12.11 Esco Aster
- 12.11.1 Esco Aster Company Information
- 12.11.2 Esco Aster Business Overview
- 12.11.3 Esco Aster Revenue in Plasmid DNA (pDNA) Business (2021-2026)
- 12.11.4 Esco Aster Plasmid DNA (pDNA) Product Portfolio
- 12.11.5 Esco Aster Recent Developments
- 12.12 Creative Biolabs
- 12.12.1 Creative Biolabs Company Information
- 12.12.2 Creative Biolabs Business Overview
- 12.12.3 Creative Biolabs Revenue in Plasmid DNA (pDNA) Business (2021-2026)
- 12.12.4 Creative Biolabs Plasmid DNA (pDNA) Product Portfolio
- 12.12.5 Creative Biolabs Recent Developments
- 12.13 Charles River Laboratories
- 12.13.1 Charles River Laboratories Company Information
- 12.13.2 Charles River Laboratories Business Overview
- 12.13.3 Charles River Laboratories Revenue in Plasmid DNA (pDNA) Business (2021-2026)
- 12.13.4 Charles River Laboratories Plasmid DNA (pDNA) Product Portfolio
- 12.13.5 Charles River Laboratories Recent Developments
- 12.14 Catalent Biologics
- 12.14.1 Catalent Biologics Company Information
- 12.14.2 Catalent Biologics Business Overview
- 12.14.3 Catalent Biologics Revenue in Plasmid DNA (pDNA) Business (2021-2026)
- 12.14.4 Catalent Biologics Plasmid DNA (pDNA) Product Portfolio
- 12.14.5 Catalent Biologics Recent Developments
- 12.15 Biovian
- 12.15.1 Biovian Company Information
- 12.15.2 Biovian Business Overview
- 12.15.3 Biovian Revenue in Plasmid DNA (pDNA) Business (2021-2026)
- 12.15.4 Biovian Plasmid DNA (pDNA) Product Portfolio
- 12.15.5 Biovian Recent Developments
- 12.16 Andelyn Biosciences
- 12.16.1 Andelyn Biosciences Company Information
- 12.16.2 Andelyn Biosciences Business Overview
- 12.16.3 Andelyn Biosciences Revenue in Plasmid DNA (pDNA) Business (2021-2026)
- 12.16.4 Andelyn Biosciences Plasmid DNA (pDNA) Product Portfolio
- 12.16.5 Andelyn Biosciences Recent Developments
- 12.17 Aldevron
- 12.17.1 Aldevron Company Information
- 12.17.2 Aldevron Business Overview
- 12.17.3 Aldevron Revenue in Plasmid DNA (pDNA) Business (2021-2026)
- 12.17.4 Aldevron Plasmid DNA (pDNA) Product Portfolio
- 12.17.5 Aldevron Recent Developments
- 12.18 Akron Biotech
- 12.18.1 Akron Biotech Company Information
- 12.18.2 Akron Biotech Business Overview
- 12.18.3 Akron Biotech Revenue in Plasmid DNA (pDNA) Business (2021-2026)
- 12.18.4 Akron Biotech Plasmid DNA (pDNA) Product Portfolio
- 12.18.5 Akron Biotech Recent Developments
- 12.19 AGC Biologics
- 12.19.1 AGC Biologics Company Information
- 12.19.2 AGC Biologics Business Overview
- 12.19.3 AGC Biologics Revenue in Plasmid DNA (pDNA) Business (2021-2026)
- 12.19.4 AGC Biologics Plasmid DNA (pDNA) Product Portfolio
- 12.19.5 AGC Biologics Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst